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PECULIARITIES OF ANTIOXIDANT SYSTEM AND IRON 
METABOLISM IN ORGANISM DURING DEVELOPMENT OF TUMOR 
RESISTANCE TO CISPLATIN
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Aim: To study in vivo the peculiarities of changes of iron metabolism and antioxidant system in dynamics of growth of Guerin car-
cinoma with different sensitivity to cisplatin. Materials and Methods: In order to evaluate the content of metallothionein-1 (MT-1) 
in tumor homogenates and blood serum of rats with cisplatin-sensitive and cisplatin-resistant Guerin carcinoma the immunoenzyme 
method was used. The evaluation of ceruloplasmin activity, content of “free iron” complexes, superoxide and NO-generating acti-
vity of NADPH-oxidase and iNOS activity in neutrophils, blood serum and tumor homogenates was measured by EPR-spectro-
scopy. Results: Maximal accumulation of MT-1 in blood serum and tumor, more pronounced in resistant strain, at the border 
of latent and exponential phase of growth has been shown that is the evidence of protective role of this protein in the respect 
to the generation of free radical compounds. It has been determined that in animals with cisplatin-resistant strain of Guerin car-
cinoma, increase of “free iron” complexes is more apparent both on the level of tumor and organism on the background on increase 
of CP/TR ratio that is the consequence of organism antioxidant protection system disorder. Conclutions: Mentioned changes 
in metabolism of iron with its accumulation in tumor and further reprogramming of mitochondria metabolism and activity of NADPH-
oxidase for non-transformed cells are favorable conditions for the formation of oxidative phenotype of tumor.
Key Words: Guerin carcinoma, metallothionein-1, antioxidant system, transferrin, ceruloplasmin, “free iron” complexes, activity 
of NADPH-oxidase and iNOS neutrophils.
Today, condition of antioxidant system (AOS) has 
significant place in the chain of insufficiently studied 
rearrangements occurring in the organism of host 
in the process of development of neoplasm. It has been 
proved that activation of oxidative processes, which cause 
disintegration of cellular membranes and destabilization 
of many elements of metabolism underlie pathological 
changes associated with malignant transformation of cell. 
The increase of oxidation of lipids, proteins and DNA 
becomes more intensive during progression of tumor 
process. It has been determined that tumor progression 
is accompanied with development of oxidative stress and 
this consequently requires effective mechanisms of pro-
tection from damaging impact of reactive oxygen species 
(ROS) and other free radical compounds. The system in-
activating free radical compounds is AOS. By localization, 
antioxidant protection system is divided into the intra- and 
extracellular antioxidants. To the intracellular antioxidants 
are referred glutathione, α-tocopherol,  Zn/ Mg-SOD, 
catalase, glutathione peroxidase, ferritin and other. 
System of extracellular antioxidants consists of low-
molecular substances (ascorbic and uric acids, bilirubin) 
and high-molecular compounds (extracellular superoxide 
dismutase, SH-groups of proteins, ceruloplasmin — 
CP and transferrin — TR). Development of tumors causes 
the activation of AOS of blood, in particular, involvement 
of CP and TR [1–4]. CP is known to be multifunctional 
copper-containing protein — oxidase of α2-globulin 
fraction of blood plasma of mammals, which performs 
non-specific protection at exo- and endogenous da-
mages. Also, it is connected with hematopoietic system 
playing role of the catalyst in transformation of Fe2+ 
in Fe3+ with its followed including in apo-transferrin. 
It has been determined that development of malignant 
process causes accumulation in organism of “free iron” 
(Fe2+), which activates processes of lipid peroxidation 
(LPO) that causes in turn increase of antioxidant acti-
vity of blood serum,  exactly activity of CP and TR [6–8]. 
By its origin, TR is single chain iron-containing glyco-
protein of β-globulin fraction of blood serum, which 
plays the main role in transfer and regulation of iron 
metabolism in tissues and also impacts the antioxidant 
potential of blood. It should be mentioned that CP along 
with TR forms molecular system able to regulate content 
of iron ions (Fe2+), total antioxidant activity of blood serum 
and oxidation of Fe2+ by CP. It has been showed that CP/
TR (lactoferrin) ratio increases in cancer patients com-
pared with indices of healthy people that is the evidence 
of significant content of Fe2+ as a pro-oxidant marker [4, 
6–11]. Thus, complicated system of interaction between 
CP and TR, which is fully connected with transformation 
and redistribution of iron in organism with its further 
involvement in the processes of generation of ROS, 
proves once again the importance of this microelement 
in occurrence and development of malignant neoplasm.
In recent time, significant attention was given to one 
more little-studied component of AOS of organism — 
metallothionein (MT). For instance, it has been showed 
that MT owing to significant content of SH-bonds 
is capable to change redox-condition and act as ac-
tive interceptor of superoxide radicals [12–14]. For 
this reason, evaluation and analysis of the processes, 
which allow cells to regulate reaction to exo- and 
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 endo genous impacts at tumor process, have very 
important practical significance. On the example 
of antioxidant protection in development of malignant 
neoplasms in organism, conception of “tumor-host” 
interaction is confirmed. Study of AOS of organism 
(exactly chelators of metal ions with variable atomicity, 
MT-1) and parallel determination of “free iron” com-
plexes and generation of ROS, especially taking into 
account sensitivity of malignant neoplasm to antitumor 
drugs, is insufficiently studied direction in oncology.
Taking into account mentioned above, the aim 
of our study was to analyze the peculiarities of iron 
metabolism and AOS in organism of host in dynamics 
of tumor drug resistance development.
MATERIALS AND METHODS
Animals and experimental model. Object of our 
study included 80 male rats with sensitive and resistant 
to cisplatin Guerin carcinoma. Guerin carcinoma was 
transplanted subcutaneously (2 × 106 cells/rat). Resistant 
strain was obtained through subsequent transplantations 
of Guerin carcinoma after carrying out of chemotherapy 
course with cisplatin to the rats. To obtain resistant tumor, 
10 courses of chemotherapy were carried out. All animals 
were decapitated with adhering current bioethical norms. 
According with the aim of study, change in the level 
of metal-containing proteins in blood of animals was 
determined in different periods of growth of Guerin 
carcinoma — 1, 3, 5, 7, 17 and 23 days after transplanta-
tion. By conventional bioethics, 1–5 day of development 
of tumor is considered as latent growth period, 6–14 day 
is referred to the phase of exponential growth, and 
23 day — to the terminal phase of tumor growth.
In blood serum and tumor tissue of experimental 
animals, content of the following metal-containing pro-
teins was studied: MT-1 and TR [4]. Also, in blood and 
tumors of these animals, “free iron” complexes were 
determined [2]. Moreover, in blood of experimental 
rats, activity of CP and superoxide- and NO-generating 
activity of NADPH-oxidase, iNOS neutrophils was de-
termined. In tumor tissue, level of superoxide radicals 
in mitochondria was registered. Mentioned above 
indices in tumor were studied on 7th, 14th and 23rd days 
after its transplantation, exactly in those periods, when 
changes may obtain essential significance.
Evaluation of the content of MT-1 in blood se-
rum and tumor homogenates of rats with Guerin 
carcinoma by immunoenzyme method. Content 
of MT-1 in blood serum and tumor homogenate was 
determined by immunoenzyme method — IEM (ELISA) 
using appropriate kits of reagents: USCN (China) with 
the help of automatic biochemical and immunoenzyme 
analyzer Chem Well 2990. Samples of blood serum for 
IEM were obtained according with the recommenda-
tions indicated in instructions to the kits. All samples 
of blood serum had no signs of hemolysis. Homo-
genate of tumor tissue was obtained in physiological 
solution in the ratio of ⅓.
E v a l u a t i o n  o f  C P  a c t i v i t y ,  c o n t e n t 
of TR, “free iron” complexes and superoxide- 
and  NO-gene rating activity of NADPH-oxidase, 
iNOS neutrophils in blood of experimental animals 
by EPR. In blood of experimental animals, activity 
of CP and content of TR, quantity of “free iron” com-
plexes and super oxide- and NO-generating activity 
of NADPH-oxidase, iNOS neutrophils were analyzed 
by method of electron paramagnetic resonance (EPR) 
at the temperature of liquid nitrogen 77 K. As antico-
agulant, trilon B was used. Samples for the study with 
computerized spectrometer were prepared using spe-
cial press-form with followed freezing in liquid nitrogen.
Determination of content of TR, “free iron” 
complexes and levels of superoxide radicals in tu-
mor tissue of experimental animals by EPR. To de-
termine these indices, 0.5 g of tumor tissue was placed 
in special press-forms and frozen in liquid nitrogen. Af-
ter this, EPR was applied using spin trap — 1-hydroxy-
2,2,6,6-tetramethyl-4-oxo-piperidine hydrochloride 
(TEMPONE-H) [4].
Statistical analysis. Significance of differences 
between indices of different groups was evaluated 
 using Student’s t-criterion. Differences were con-
sidered significant at р<0.05. Statistical processing 
of data was carried out using software STATISTICA 6.0.
RESULTS AND DISCUSSION
Studies showed that from 1st to 7th day after trans-
plantation of tumor, gradual increase of MT-1 was ob-
served in blood serum of animals. Maximal value of this 
index both in tumor and blood serum was registered 
on 7th day. It means that results of our studies prove 
that this metal-containing protein plays key role exactly 
in the end of latent and beginning of exponential stage 
of tumor growth protecting malignant neoplasm from 
reactive oxygen forms. Also, it has been confirmed 
by our data concerning generation of free radical com-
pounds exactly in mentioned period of tumor growth 
that will be discussed below. At the peak of exponential 
tumor growth (14 days after transplantation), gradual 
decrease of MT-1 in tumor tissue and blood serum was 
observed. Mentioned changes were more pronounced 
in development of resistant tumor (Table 1).
These data give ground for assumption that 
MT-1 plays important role in forming of resistant 
phenotype in animals with Guerin carcinoma. Our view 
coincides with the results of some studies, which have 
showed that due to metallothioneins, cells are ca-
pable to acquire resistance, in particular, to the tumor 
necrosis factor (TNF) [15, 16]. Presence in molecule 
of MT sulfhydryl groups with nucleophilic properties 
gives them opportunity to bind not only metal ions, but 
also ROS [13, 14]. It has been determined that high 
levels of metallothioneins are found in the places of in-
flammation and malignant transformation of tissue. 
Data of literature show that MT plays significant role 
in occurrence and development of tumor process [16, 
17]. On the example of patients with hepatocellular 
carcinoma, it has been shown that high expres-
sion of MT-1 in tumors correlates with low efficacy 
of chemotherapy with carboplatin [18]. It has been 
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shown that hyperexpression of MT is antiapoptotic 
and stimulates increase the proliferative activity of tu-
mor cells. MT activates and specifically interacts with 
p50 (subunit of NFkB transcription factor) that causes 
the transactivation of the latter [14].
Table 1. Content of MT-1 in tumor tissue and blood serum of animals 
with Guerin carcinoma in different stages of its growth
Groups 
of animals 
by periods 
after trans-
plantation
Content of МТ-1, pg/ml
Sensitive strain Resistant strain
serum tumor serum tumor
Control 
(intact ani-
mals) 
282.40±9.73 − 279.40±8.23 −
1 day 319.41±14.23 − 320.10±15.14 −
3 days 334.22±17.13* − 350.12±19.80* −
5 days 535.10±34.50* − 750.34±21.18* −
7 days 634.20±31.23* 740.33±23.14 820.10±32.14* 920.43±38.12*
14 days 424.12±9.24* 510.18±28.10* 506.92±15.52* 512.31±21.18*
23 days 423.64±13.51* 390.14±16.13* 399.61±10.21* 490.12±31.21*
Note: *р < 0.05 — significant regarding control values.
Till this day, condition of extracellular high-molecular 
AOS of blood at development of malignant neoplasm 
remains insufficiently studied. As stated above, exactly 
such proteins, as TR and CP in blood plasma, form AOS 
that regulates concentration of renewed iron ions [4, 
18]. The main role in antioxidant protection of orga nism 
is performed by these proteins due to the inhibition 
of iron-induced peroxidation of the components of ex-
tracellular environment (i.e., due to the oxidase activity 
of CP and iron-binding and transport function of TR). 
First of all, we draw attention to the one of the proteins, 
which participates in iron metabolism, exactly — TR. Ac-
cording with data of li terature, decrease of TR in dyna-
mics of tumor growth in 2.5–3 times on the background 
of simultaneous increase of CP in 1.5–2 times occurs 
in blood plasma of animals [19].
Results of our studies of TR content in blood of ex-
perimental animals with Guerin carcinoma (sensitive 
and resistant strains) showed that almost on the first 
day of tumor growth, its level in blood starts gradually 
decreasing compared with control (Table 2). In tumor 
tissue of sensitive to cisplatin strain of Guerin carci-
noma, level of TR remained on the same level both 
in latent and exponential growth phases. In the end 
of terminal growth phase, insignificant decrease 
of this index was observed that may be connected with 
the processes of necrobiotic changes and necrosis 
in tumor. The same tendencies concerning content 
of TR were observed in blood serum and tumor of re-
sistant strain.
Table 2. Content of TR in tumor tissue and blood of animals with Guerin 
carcinoma in different stages of its growth
Groups of animals 
by periods of trans-
plantation
TR level (RU)
Sensitive strain Resistant strain
serum tumor serum tumor
Control (intact animals) 0.93±0.07 − 0.88±0.1 −
1 day 0.67±0.06 − 0.82±0.21 −
3 days 0.55±0.04* − 0.64±0.12 −
5 days 0.48±0.12* − 0.58±0.10 −
7 days 0.35±0.03* 0.15±0.05 0.47±0.12* 0.16±0.05
14 days 0.24±0.05* 0.15±0.09 0.39±0.20* 0.14±0.12
23 days 0.16±0.07* 0.10±0.05* 0.21±0.04* 0.12±0.05*
Note: *р < 0.05 — significant regarding control values.
It should be mentioned that recent publications 
on mechanisms of metal metabolism in organism 
point at significant role of TR in transfer and accumu-
lation of iron. For instance, on the example of cell line 
of small cell lung carcinoma NCL-H510, expression 
of this protein on their surface was detected by method 
of immune fluorescence [20]. Also, it has been de-
termined that synthesis of TR 10 times increases 
during cell proliferation. Thus, it has been proved 
in study that hyperexpression of TR induces cellular 
proliferation, but fully depends on regulatory system 
of iron metabolism (auto crine mechanism of regula-
tion) [20]. Other studies in vivo showed that at pre-
sence in organism of malignant process, decrease 
of content of TR and decrease of iron concentration 
in blood serum occurs [21–23]. It results in disorder 
of iron transfer from blood serum to ferritin in tumor 
cells that is the evidence of accumulation and storage 
of iron ions in tumor cells. Since another one metal-
containing protein, which is a part of extracellular high-
molecular AOS of organism and indirectly participates 
in the processes of recovery and oxidation of iron 
in blood, is CP, we decided to study activity of this 
protein in host blood, as well as to analyze CP/ TR ra-
tio in dynamics of tumor growth as marker of reserve 
possibility of AOS (Table 3).
Table 3. Activity of CP and CP/TR ratio in blood of animals with Guerin 
carcinoma in different stages of its growth
Groups of animals 
by periods of trans-
plantation
CP activity (RU)
Sensitive strain Resistant strain
CP CP/TR CP CP/TR
Control (intact animals) 0.86 ± 0.09 0.92 0.88 ± 0.1 0.85
1 day 1.94 ± 0.11 1.49* 0.48 ± 0.06 0.58*
3 days 5.51 ± 0.09* 10.01* 0.50 ± 0.04 0.78
5 days 7.21 ± 0.16* 15.02* 0.69 ± 0.09 1.18
7 days 7.03 ± 0.10* 20.08* 1.13 ± 0.25* 2.40
14 days 5.79 ± 0.12* 24.12* 1.8 ± 0.18* 4.61
23 days 5.99 ± 0.15* 37.43* 2.76 ± 0.31 13.14
Note: *р < 0.05 — significant regarding control values.
Obtained results prove that along with decrease 
of content of TR (Table 2), increase of CP activity oc-
curs (Table 3) in blood of animals with sensitive and 
resistant Guerin carcinoma that is the evidence of dis-
order of iron transport in host organism. After all, ratio 
CP/TR increases, and it may cause the increase of “free 
iron” concentration. Thus, as activity of CP and TR al-
ters, disorder of balance oxidant/antioxidant occurs 
with further development of oxidative stress. However, 
values of CP/TR in different stages of tumor growth 
were lower in blood of animals with resistant strain, 
than in blood of animals with sensitive strain. It can 
be explained by the fact that as resistance of cisplatin 
forms, changes in transportation of the component 
of CP, copper, occurs due to the series of proteins-
transporters. Moreover, according to the data of lit-
erature, key protein-transporter of copper CTR1 plays 
important role not only in transporting of copper, but 
also cisplatin. Authors of these studies showed that, 
on the one hand, copper is required for transporta-
tion of platinum inside cell, and, on the other hand, 
it competes with platinum for the sites of binding [24]. 
Series of studies on cellular lines of breast and ovarian 
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cancer resistant to cisplatin have showed alteration 
in expression of series of proteins-transporters of cop-
per: CTR1, ATP7A, ATP7B, which also are involved 
in transportation of cisplatin and its derivatives. Direct 
correlation between delivery of copper and cisplatin 
in cells and decrease of transportation of these met-
als in tumor with phenotype resistant to cisplatin has 
been determined [25]. Clinical studies showed direct 
correlation between increase of concentrations of cop-
per and CP in blood serum of patients with breast, 
ovarian, lung, and intestine cancers and progression 
of tumor process [26]. For this reason, we have made 
an assumption that low levels of CP activity in blood 
of animals with resistant to cisplatin strain (regarding 
indices of sensitive strain) are connected with disorder 
of transportation of copper as a result of decrease 
of expression of proteins-transporters CTR1, АТР7А, 
АТР7В.
It has been determined that at malignant trans-
formation, which is accompanied with disorder 
of iron metabolism in organism, misbalance of system 
of antioxidant protection with involvement of metal-
containing proteins CP and TR is observed. Total 
antioxidant activity of serum concerning Fe2+-induced 
LPO is mainly depended on content of these proteins. 
It should be mentioned that exactly TR binds iron ions 
Fe3+ that prevents their renewal and participation 
in Fenton/Haber — Weiss reaction, which indirectly 
causes release of free radical compounds with further 
damage of many metabolic processes [9, 10]. It has 
been shown that interaction between metals (first 
of all iron) and hydrogen peroxide results in forma-
tion of the most toxic form of ROS. It damages DNA, 
RNA as well as carbohydrates, amino acids and lipids. 
Moreover, presence of ions of these metals may cause 
spontaneous and induced oxide modification of pro-
teins. It is known that these changes acquire higher 
sensitivity to proteolysis that causes invasion of tumor 
in surrounding tissues [10].
For the full understanding of changes of CP and 
TR as metal-containing proteins, as well as important 
components of AOS, we have studied quantity of “free 
iron” complexes in dynamics of tumor growth both 
in tumor tissue and peripheral blood.
Obtained results showed that increase of “free 
iron” complexes in tumor tissue of both strains in dy-
namics of development of malignant neoplasms was 
accompanied with simultaneous increase of the rate 
of generation of superoxide radicals (Table 4). 
 However, stronger increase of level of superoxide 
radicals was observed in resistant tumors, especially 
23 days after transplantation. It demonstrates that for 
resistant tumors, more active generating of superoxide 
radicals is typical compared with sensitive tumors that 
in turn causes more apparent destabilization of iron-
containing proteins. Moreover, we have determined 
direct correlation between increase of rate of ge-
nerating of superoxide radicals and number of “free 
iron” complexes in sensitive (r = 0.98) and resistant 
(r = 0.79) tumors.
Table 4. Number of “free iron” complexes and rate of generating of su-
peroxide radicals in tumor tissue of Guerin carcinoma in different stages 
of its growth
Groups 
of ani mals 
by periods af-
ter transplan-
tation
“Free iron” complexes (RU)
Rate of generating of su-
peroxide radicals in tumor 
tissue (nmol/g of fresh 
tissue·min)
Sensitive 
strain
Resistant 
strain
Sensitive 
strain
Resistant 
strain
7 days 0.19 ± 0.08 0.21 ± 0.07 0.50 ± 0.1 0.51 ± 0.23
14 days 0.61 ± 0.05* 0.68 ± 0.04* 0.51 ± 0.1 0.63 ± 0.18
23 days 1.95 ± 0.08* 2.00 ± 0.08* 0.56 ± 0.09 0.64 ± 0.11*
Note: *р < 0.05 — significant regarding control values.
At the same time, number of “free iron” complexes 
in peripheral blood of the same animals in dynamics 
of malignant process was studied. It is well-known that 
emergence of “free iron” in blood is stipulated by acti-
vation of LPO and damage of membranes, hemolysis, 
destruction of iron-containing proteins, transformation 
of Fe3+-transferrin in apo-transferrin: Fe3+-TR е-→ Fe2+ + 
apo-TR, as well as release of deposited iron from ferritin. 
It is also known that ions Fe2+ play important role in LPO, 
and iron “overload” of organism causes damage of cel-
lular structures. Low-molecular iron complexes are pro-
moters of free radical reactions, and emergence of “free 
iron” pool in blood causes the formation of ·ОН and О2..
Our studies have determined increase of “free iron” 
complexes in peripheral blood of animals in dynamics 
of growth of both tumor strains (Figure).
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Figure. Number of “free iron” complexes in peripheral blood 
of rats with sensitive and resistant Guerin carcinoma in dyna-
mics of tumor growth
It should be mentioned that in peripheral blood 
of intact animals, “free iron” complexes were not 
detected. Mentioned increase of level of superoxide 
radicals and “free iron” complexes in experimental 
animals are the evidence of development of oxidative 
stress. Moreover, we have studied rate of generating 
of superoxide radicals by NADPH-oxidase and activity 
of iNOS neutrophils depending on phases of growth 
of Guerin carcinoma of both strains. Gradual increase 
of these indices from the beginning of tumor growth 
compared with their values in corresponding controls 
has been determined (Table 5). As seen from Table 5, 
changes of activity of NADPH-oxidase and iNOS 
neutrophils in blood of animals with Guerin carcinoma 
in dynamics of growth of both sensitive and resistant 
strains are unidirectional. However, in blood of animals 
with resistant strain, these indices are slightly higher, 
than in animals with sensitive tumor strain.
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Table 5. Rate of generating of superoxide radicals by NADPH-oxidase and 
iNOS neutrophils of rat blood in dynamics of Guerin carcinoma growth
Groups 
of animals 
by periods af-
ter transplan-
tation
Activity of NADPH-
oxidase of neutrophils 
(nmol/103 cells·min)
Activity of iNOS neutrophils 
(nmol/103 cells·min)
Sensitive 
strain
Resistant 
strain
Sensitive 
strain
Resistant 
strain
Control (in-
tact animals)
0.28 ± 0.05 0.29 ± 0.04 1.60 ± 0.02 1.76 ± 0.04
1 day 0.70 ± 0.03* 0.77 ± 0.02* 2.01 ± 0.07 2.04 ± 0.05
3 days 0.98 ± 0.09* 0.96 ± 0.09* 2.15 ± 0.11* 2.11 ± 0.12*
5 days 1.08 ± 0.09* 1.12 ± 0.08* 2.95 ± 0.15* 3.55 ± 0.15*
7 days 2.12 ± 0.03* 2.09 ± 0.01* 3.71 ± 0.20* 3.80 ± 0.16*
14 days 1.95 ± 0.02* 2.35 ± 0.18* 4.12 ± 0.10* 3.95 ± 0.15*
23 days 1.98 ± 0.05* 2.46 ± 0.19* 3.79 ± 0.06* 4.16 ± 0.21*
Note: *р < 0.05 — significant regarding control values.
To determine connection between indices of iron 
metabolism and indices of oxidative stress, we have 
carried out study using correlation analysis. Results have 
showed that increase of “free iron” complexes in periphe-
ral blood is accompanied by activation of generating 
superoxide radicals by NADPH-oxidase with prevalence 
in resistant tumors (r = 0.59 at growth of sensitive and r 
= 0.70 — resistant tumor). This fact points at the most 
essential disorders in iron metabolism in organism of tu-
mor host at development of resistant tumor. It has been 
determined that as number of “free iron” complexes 
in peripheral blood of animals increases, activity of iNOS 
neutrophils also significantly increases (r = 0.50 at sensi-
tive and r = 0.76 at resistant tumor). Also, we have proved 
direct correlation between content of powerful antioxi-
dant MT-1 and activity of NADPH-oxidase of neutrophils 
of sensitive (r = 0.67) and resistant (r = 0.51) tumor. Simi-
larly, direct correlation between level of MT-1 and activity 
of iNOS of neutrophils of sensitive (r = 0.67) and resistant 
(r = 0.65) strains has been determined. There is an idea 
in literature that MT-1 performs protective role from dam-
aging action of superoxide radicals due to the SH-bonds 
and cysteine as components of this metal-containing 
protein [17]. On the example of Guerin carcinoma, it has 
been shown that increase of content of MT-1 in tumor 
tissue of resistant strain directly correlates with high level 
of generation of superoxide radicals in it (r = 0.72). This 
coefficient was lesser in sensitive tumor and equaled r 
= 0.59. Obtained results demonstrate that MT-1 in the 
process of Guerin carcinoma growth plays important 
role in antioxidant protection of transformed cells from 
destructive impact of free radical compounds.
Thus, in animals with sensitive and resistant to cis-
platin Guerin carcinoma, change of condition of AOS 
components was determined in dynamics of tumor 
growth: content of MT-1, TR and activity of CP that 
points at disorder of iron metabolism in host organism.
In conclusion, on the model of Guerin carcinoma 
with sensitive and resistant to cisplatin strains, misba-
lance of regulatory proteins of iron metabolism has been 
shown: MT-1, TR and CP in dynamics of deve lopment 
of tumor process on the level of complicated system 
of interaction between tumor and organism. It has been 
determined that in the initial stages of development 
of neoplasm, changes in two functionally coupled com-
ponents of pro- and AOS takes place in blood serum 
and tumor tissue of animals: significant increase of ge-
nerating superoxide radicals and simultaneous increase 
of MT-1. It has been determined that in dynamics of tu-
mor growth in animals of both strains, increase of “free 
iron” complexes both in tumor tissue and blood serum 
takes place on the background of significant increase 
of CP/TR ratio that shows disorder of functioning of host 
AOS which participates in the recovery processes and 
iron oxidation. In animals with strain resistant to cispla-
tin, mentioned changes were more pronounced that 
was manifested by increase of number of “free iron” 
complexes in tumor and blood of animals with further 
activation of generating superoxide radicals. It has been 
shown that tumor cells are capable to alter metabolism 
of iron via its accumulation in malignant neoplasm with 
followed reprogramming of mitochondria metabolism 
and activity of NADPH-oxidase of non-transformed cells 
contributing the increase of generating superoxide radi-
cals. Mentioned changes are favorable for the formation 
of oxidative phenotype and appropriate conditions for 
the progression of tumor lesion.
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